Repro Med Systems, Inc. announced that Karen Fisher, the Company's Chief Financial Officer, will resign her employment, effective from June 30, 2022 to pursue other opportunities. There were no disagreements between Ms. Fisher and the Company. Ms. Fisher's departure is not related to the operations, policies or practices of the Company or any issues regarding accounting policies or practices.

The Company has engaged a specialized firm to conduct a search of potential candidates to replace Ms. Fisher. In the interim, the Company's Vice President of Financial Planning and Analysis, Tom Adams, will serve as Interim Chief Financial Officer of the Company, effective from July 1, 2022.